Literature DB >> 35384562

Risk factors for motor complications in female patients with Parkinson's disease.

Zhirong Wan1,2,3,4, Xuemei Wang1, Huizi Ma1, Zhan Wang1, Tao Feng5,6,7.   

Abstract

OBJECTIVE: To investigate the risk factors of motor complications in female patients with Parkinson's disease (PD) and the correlation between the occurrence of motor complications and sex hormone levels.
METHODS: According to the occurrence and types of motor complications, 103 female PD patients were divided into two groups: patients with or without the wearing-off phenomenon, patients with or without dyskinesia. Binary logistic regression analysis was performed respectively to screen for the risk factors of the wearing-off phenomenon and dyskinesia in female PD patients.
RESULTS: Among 103 female PD patients, 44 (42.72%) had motor complications. Patients with the wearing-off phenomenon and patients with dyskinesia had higher prolactin levels than patients without the wearing-off phenomenon and patients without dyskinesia, respectively. However, the difference was no longer significant when the two groups were corrected for multiple comparisons (P < 0.0028). Multivariate analysis found that younger age at onset and higher Hoehn-Yahr (H&Y) stage were identified as independent risk factors for the wearing-off phenomenon and younger age of onset was an independent risk factor for dyskinesia in female PD patients (P < 0.05).
CONCLUSION: Female PD patients have a higher incidence of motor complications. Younger age of onset and higher H&Y stage were the risk factors of the wearing-off phenomenon, and younger onset age was the risk factor of dyskinesia in female PD patients. There may be a certain correlation between the occurrence of motor complications and sex hormone levels in female PD patients, which requires further verification.
© 2022. Fondazione Società Italiana di Neurologia.

Entities:  

Keywords:  Dyskinesia; Female; Parkinson’s disease; Risk factors; Sex hormone; Wearing-off phenomenon

Mesh:

Substances:

Year:  2022        PMID: 35384562     DOI: 10.1007/s10072-022-05959-3

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.830


  8 in total

1.  Clinical Characteristics of Parkinson's Disease Developed from Essential Tremor.

Authors:  Dong-Woo Ryu; Si-Hoon Lee; Yoon-Sang Oh; Jae-Young An; Jeong-Wook Park; In-Uk Song; Kwang-Soo Lee; Joong-Seok Kim
Journal:  J Parkinsons Dis       Date:  2017       Impact factor: 5.568

2.  Overexpression of TFEB Drives a Pleiotropic Neurotrophic Effect and Prevents Parkinson's Disease-Related Neurodegeneration.

Authors:  Albert Torra; Annabelle Parent; Thais Cuadros; Beatriz Rodríguez-Galván; Esther Ruiz-Bronchal; Andrea Ballabio; Analía Bortolozzi; Miquel Vila; Jordi Bové
Journal:  Mol Ther       Date:  2018-02-27       Impact factor: 11.454

3.  Beyond 35 years of Parkinson's disease: a comprehensive clinical and instrumental assessment.

Authors:  Alberto Romagnolo; Margherita Fabbri; Aristide Merola; Elisa Montanaro; Sara Palermo; Tiziana Martone; Agostino Seresini; Stefano Goldwurm; Mario Giorgio Rizzone; Leonardo Lopiano
Journal:  J Neurol       Date:  2018-06-26       Impact factor: 4.849

Review 4.  Therapeutic strategies to prevent and manage dyskinesias in Parkinson's disease.

Authors:  Manuela Pilleri; Angelo Antonini
Journal:  Expert Opin Drug Saf       Date:  2014-12-06       Impact factor: 4.250

5.  Elemental fingerprint as a cerebrospinal fluid biomarker for the diagnosis of Parkinson's disease.

Authors:  Fabian Maass; Bernhard Michalke; Andreas Leha; Matthias Boerger; Inga Zerr; Jan-Christoph Koch; Lars Tönges; Mathias Bähr; Paul Lingor
Journal:  J Neurochem       Date:  2018-04-02       Impact factor: 5.372

6.  l-Dopa responsiveness is associated with distinctive connectivity patterns in advanced Parkinson's disease.

Authors:  Harith Akram; Chengyuan Wu; Jonathan Hyam; Thomas Foltynie; Patricia Limousin; Enrico De Vita; Tarek Yousry; Marjan Jahanshahi; Marwan Hariz; Timothy Behrens; John Ashburner; Ludvic Zrinzo
Journal:  Mov Disord       Date:  2017-05-08       Impact factor: 10.338

7.  Effect on Gait Speed, Balance, Motor Symptom Rating, and Quality of Life in Those with Stage I Parkinson's Disease Utilizing LSVT BIG®.

Authors:  Beth Millage; Erin Vesey; Marsha Finkelstein; Mattie Anheluk
Journal:  Rehabil Res Pract       Date:  2017-02-26

8.  Factors associated with motor complications in Parkinson's disease.

Authors:  Liis Kadastik-Eerme; Nele Taba; Toomas Asser; Pille Taba
Journal:  Brain Behav       Date:  2017-09-25       Impact factor: 2.708

  8 in total
  1 in total

1.  Sex Differences in Parkinson's Disease: From Bench to Bedside.

Authors:  Maria Claudia Russillo; Valentina Andreozzi; Roberto Erro; Marina Picillo; Marianna Amboni; Sofia Cuoco; Paolo Barone; Maria Teresa Pellecchia
Journal:  Brain Sci       Date:  2022-07-13
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.